These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 23459599

  • 1. Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats.
    Varagic J, Ahmad S, VonCannon JL, Moniwa N, Brosnihan KB, Wysocki J, Batlle D, Ferrario CM.
    Am J Hypertens; 2013 May; 26(5):583-90. PubMed ID: 23459599
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension.
    Moniwa N, Varagic J, Ahmad S, VonCannon JL, Simington SW, Wang H, Groban L, Brosnihan KB, Nagata S, Kato J, Kitamura K, Gomez RA, Lopez ML, Ferrario CM.
    Hypertension; 2013 Feb; 61(2):417-24. PubMed ID: 23232645
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients.
    Ichikawa S, Takayama Y.
    Hypertens Res; 2001 Nov; 24(6):641-6. PubMed ID: 11768722
    [Abstract] [Full Text] [Related]

  • 6. Role of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis in the hypotensive effect of azilsartan.
    Iwanami J, Mogi M, Tsukuda K, Wang XL, Nakaoka H, Ohshima K, Chisaka T, Bai HY, Kanno H, Min LJ, Horiuchi M.
    Hypertens Res; 2014 Jul; 37(7):616-20. PubMed ID: 24599018
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activation of angiotensin-(1-7)/Mas axis in the brain lowers blood pressure and attenuates cardiac remodeling in hypertensive transgenic (mRen2)27 rats.
    Kangussu LM, Guimaraes PS, Nadu AP, Melo MB, Santos RA, Campagnole-Santos MJ.
    Neuropharmacology; 2015 Oct; 97():58-66. PubMed ID: 25983274
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1-7 mas receptor.
    Sukumaran V, Veeraveedu PT, Lakshmanan AP, Gurusamy N, Yamaguchi K, Ma M, Suzuki K, Kodama M, Watanabe K.
    Free Radic Res; 2012 Jul; 46(7):850-60. PubMed ID: 22497476
    [Abstract] [Full Text] [Related]

  • 12. Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
    Červenka L, Bíbová J, Husková Z, Vaňourková Z, Kramer HJ, Herget J, Jíchová Š, Sadowski J, Hampl V.
    Physiol Res; 2015 Jul; 64(1):11-24. PubMed ID: 25194129
    [Abstract] [Full Text] [Related]

  • 13. Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension.
    Savoia C, Arrabito E, Parente R, Nicoletti C, Madaro L, Battistoni A, Filippini A, Steckelings UM, Touyz RM, Volpe M.
    Hypertension; 2020 Dec; 76(6):1753-1761. PubMed ID: 33070664
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Ann Tallant E, Smith RD, Chappell MC.
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [Abstract] [Full Text] [Related]

  • 16. Long-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats.
    Gilliam-Davis S, Payne VS, Kasper SO, Tommasi EN, Robbins ME, Diz DI.
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1327-33. PubMed ID: 17616746
    [Abstract] [Full Text] [Related]

  • 17. Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats.
    Moniwa N, Varagic J, Ahmad S, VonCannon JL, Ferrario CM.
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):15-29. PubMed ID: 22222314
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade.
    Igase M, Kohara K, Nagai T, Miki T, Ferrario CM.
    Hypertens Res; 2008 Mar; 31(3):553-9. PubMed ID: 18497476
    [Abstract] [Full Text] [Related]

  • 19. Olmesartan improves endothelin-induced hypertension and oxidative stress in rats.
    Yao L, Kobori H, Rahman M, Seth DM, Shokoji T, Fan Y, Zhang GX, Kimura S, Abe Y, Nishiyama A.
    Hypertens Res; 2004 Jul; 27(7):493-500. PubMed ID: 15302986
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension.
    Tsutamoto T, Nishiyama K, Yamaji M, Kawahara C, Fujii M, Yamamoto T, Horie M.
    Hypertens Res; 2010 Feb; 33(2):118-22. PubMed ID: 19927151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.